Position in VRTX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$78,483
+$7,930 QoQ
Shares Held
158
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,496
of 1,735 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PFS Partners, LLC holds $1,629,815 across 9 Biotechnology names. VRTX ranks #2 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
79,000 | $1,473,350 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
158 | $78,483 | |
| 3 | AVTX |
Avalo Therapeutics, Inc.
|
2,000 | $36,960 | |
| 4 | ENGN |
enGene Therapeutics Inc.
|
11,000 | $19,030 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24 | $14,964 | |
| 6 | TECH |
BIO-TECHNE Corp
|
67 | $4,733 | |
| 7 | PRQR |
ProQR Therapeutics N.V.
|
1,000 | $1,860 | |
| 8 | EXEL |
Exelixis, Inc.
|
8 | $435 |
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,483 | 158 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $70,553 | 158 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $71,630 | 158 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $61,879 | 158 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $70,341 | 158 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $76,601 | 158 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $63,626 | 158 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $73,482 | 158 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $74,057 | 158 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $66,045 | 158 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $64,288 | 158 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $54,942 | 158 | Shares | Sole | 2023-12-01 | |
| 2023-06-30 | $55,601 | 158 | Shares | Sole | 2023-12-01 | |
| 2023-03-31 | $37,493 | 119 | Shares | Sole | 2023-12-01 | |
| 2022-12-31 | $34,364 | 119 | Shares | Sole | 2023-12-01 | |
| No filing history on record for this holder in this stock. | ||||||